Skip to main content
Markets
/
MEDANTA · NSE
Market closedNSE | BSE
Loading live market indices
ME
NSE · Equity shares · Healthcare Facilities

Global Health MEDANTA

NSE:INR 1,453Recorded price
BSE:INR 1,440.1Recorded price
Not available · Not available
Advanced chart
Data quality and coveragePrice, company fundamentals and optional research feeds are tracked separately.
Headline priceStale · last-known data
Company fundamentalsStale · last-known data
Research sections8 of 9 availableMissing source values remain unavailable, never zero-filled.
Snapshot

Price and key statistics

Reported and computed values remain separate; missing values are not converted to zero.

Previous closeData unavailable
Day rangeINR 1,403.15 — INR 1,459.9
52-week rangeINR 955.2 — INR 1,475.75
VolumeNot available
Market cap38,871.79
P/E63.47
Fundamental highlightsReported values unless marked as computed
Revenue (INR Cr)4,410.27
Net Income (INR Cr)556.46
Rev Growth (5 Year %)24.97
EPS Growth (5 Year %)80.64
P/E Ratio63.47
EPS20.69

Research path: Interpret Global Health's snapshot alongside the wider market dashboard, the financial-statement research guide and the valuation-ratios field guide.

AI and Advanced

AI analysis and Advanced tools for MEDANTA

Analysis, reports, chat and Advanced access use the same Rusaka Markets account. The backend remains authoritative for roles, subscriptions, credits and permissions.

AI analysisReview the complete evidence-led AI research workflow.Generate reportCreate a versioned report with entitlement and credit checks.Open AI ChatContinue a grounded conversation with the instrument in context.Advanced modulesOpen role- and entitlement-controlled portfolio and trading tools.
Validated OHLC

Interactive price chart

Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.

Open full workspace
Interactive price chartInteractive chart loads when this section is visible.
Auditable calculations

Daily technical summary

Calculated from validated daily candles. Descriptive research only.

Calculating technicals…
Intelligence: activity, structure and reported deals

Indicators describe price behaviour and volatility; they are not a BUY, NEUTRAL or SELL recommendation.

Company derivatives · NSE

MEDANTA futures & options

Expiry structure, futures, option chains and contract research.

Snapshot · timestamp unavailable
No observations

No matching contracts have verified observations for this filter.

DIRECTION · ACTIVITY · DISCLOSURES

MEDANTA Intelligence

Stored price, volume, causal structure and reported deals for this stock.

Market map
Checking research access…

Volume and pressure are activity estimates, not net money inflow. Futures and options retain their separate observations above.

Company reporting

Financial statements

IND AS · INR crore

Metric202620252024
Total Liabilities Shareholders' Equity5,9054,766.234,304.08
Cash Equivalents127.33148.17310.53
Other Liabilities Total166.54136.4126.61
Long Term Debt601.12264.1283.47
Common Stock Total53.7453.7253.7
Other Current Assets Total22.371.684.21
Total Assets5,9054,766.234,304.08
Current Portof LT Debt/Capital Leases62.9994.23171.89
Total Equity3,961.573,386.412,905.63
Long Term Investments114.2420.5716.09
Retained Earnings(Accumulated Deficit)3,907.832,260.661,784.03
Total Common Shares Outstanding26.8626.8626.85
Tangible Book Valueper Share Common Eq146.87125.66108.01
Total Liabilities1,943.431,379.821,398.45
Total Debt1,190.05717.73801.87
Short Term Investments1,035.05892.14750.68
Cashand Short Term Investments1,162.391,122.341,175.28
Total Receivables Net411.19324.23247.01
Accounts Receivable-Trade Net411.19314.65236.12
Property/Plant/Equipment Total-Net3,910.923,036.062,617.9
Minority Interest22.711.1-0.03
Total Current Liabilities627.13618.82617.73
Total Inventory78.9869.2874.45
Accounts Payable242.37194.81186.78
Other Currentliabilities Total321.77270.66184.55
Total Long Term Debt1,127.06623.51629.98
Intangibles Net16.211.295.54
Other Long Term Assets Total133.2557.574.09
Note Receivable-Long Term55.48107.781.73
Total Current Assets1,674.921,533.121,508.73
Capital Lease Obligations525.94359.41346.52
Accumulated Depreciation TotalNot available-1,050.13-979.02
Accrued ExpensesNot available59.1274.52
Prepaid ExpensesNot available15.67.78
Additional Paid-In CapitalNot available1,072.031,067.9
CashNot available82.03114.08
Property/Plant/Equipment Total-GrossNot available4,086.193,210.65
Notes Payable/Short Term DebtNot available00
Deferred Income TaxNot available024.16
Fundamentals

Valuation and ratios

Valuation

PEG Ratio3.78

Price to Sale Ratio8.81

Growth

Debt 5Yr CAGR %5.02

Margins

Operating Margin 12m15.2

Operating Margin 5y Avg17.09

Net Profit Margin 12m11.79

Net Profit Margin 5y12.54

Yield

Dividend Yield %0.04

Risk and consensus

Source-qualified signals

Risk metrics

Overall RiskBalanced risk

Board Risk27.8

Analyst consensus

ConsensusBuy

Consensus score2.18

Analyst opinions11

Strong Sell count0

Sell count1

Hold count4

Buy count2

Strong Buy count4

Provider consensus uses a 1 (Strong Buy) to 5 (Strong Sell) score. The payload does not include price targets, so none are inferred from 52-week prices or recommendation percentages.
Industry context

Peer comparison

Only peers present in the company profile payload are displayed.

CompanyPriceMarket capP/EResearch
Apollo Hospitals EnterpriseINR 8,812.91.27 L64.93—
Max Healthcare InstituteINR 1,0751.05 L71.47—
Fortis HealthcareINR 93570,588.5967.89—
Aster DM HealthcareINR 844.444,157.18102.55—
Narayana HrudayalayaINR 1,88138,187.3448.07—
Shareholding

Ownership

Promoter
33.00%
FII
9.46%
MF
16.03%
Other
41.51%
Corporate actions

Events

  1. dividendRs.0.5000 per share(25%)Final Dividend
  2. board MeetingsQuarterly Results
  3. board MeetingsAudited Results & Final Dividend
  4. annual General MeetingPOM
  5. board MeetingsQuarterly Results
  6. board MeetingsQuarterly Results
  7. annual General MeetingAGM
  8. dividendRs.0.5000 per share(25%)Final Dividend
  9. board MeetingsQuarterly Results
  10. board MeetingsAudited Results & Final Dividend
  11. annual General MeetingPOM
  12. board MeetingsQuarterly Results
  13. annual General MeetingPOM
  14. board MeetingsQuarterly Results
  15. annual General MeetingAGM
  16. board MeetingsQuarterly Results
  17. annual General MeetingCOM
  18. board MeetingsAudited Results
  19. board MeetingsQuarterly Results
  20. board MeetingsQuarterly Results
Rusaka Markets Community

Discussion and sentiment for Global Health

Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and Rusaka Markets AI.

Rusaka Markets Community

Community discussion loads as you approach this section.

Company profile

Business information

What the company does

Global Health Limited (Medanta) is an India-based multi-specialty tertiary care provider in the North and East regions of India. Medanta delivers advanced, end-to-end healthcare in Delhi, Gurugram, Indore, Ranchi, Patna, and Lucknow through its network of approximately five hospitals. Medanta provides healthcare services in over 30 medical specialties and engages over 1,800 doctors. Its specialty treatments are in cardiac care, cancer care, neurosciences, orthopedics, renal care, liver transplants, oncology, bone marrow transplant, obstetrics and gynecology, chest surgery, lung transplant, pediatric care, ENT, head and neck surgery, and others. Its facilities and services include medicine delivery, lab tests & diagnostics, homecare services, health checkups, elder care, air ambulance, among others. Its subsidiaries include Global Health Patliputra Private Limited, Medanta Holdings Private Limited, and GHL Pharma & Diagnostic Private Limited.

Company facts

Industry
Healthcare Facilities
Sector
Healthcare Facilities
NSE Code
MEDANTA
BSE Code
543654
Questions

Stock FAQ

What is the symbol and ISIN of Global Health?

Global Health has the symbol MEDANTA and ISIN - INE474Q01031.

What is the latest recorded price of Global Health?

The latest available recorded price of Global Health is INR 1,453.00 as of 2026-08-06T20:49:44.968Z. This is a source-stamped snapshot, not a live quote.

What are the year high and year low of Global Health?

Year high: INR 1,475.75. Year low: INR 955.20.

What is the market capitalization of Global Health?

Market capitalization: INR 38,871.79 crore.

What is the P/E ratio of Global Health?

P/E ratio: 63.47.

What is the dividend yield of Global Health?

Dividend yield: 0.04%.

How is the financial performance of Global Health based on revenue, net income, and EPS?

Revenue: INR 4,410.27 crore. Net income: INR 556.46 crore. EPS: INR 21.29.

What are the price-to-book and price-to-sales ratios of Global Health?

Price-to-book ratio is unavailable in the current source. Price-to-sales ratio: 8.81.

Corporate-action adjustment is provider-defined. Rusaka Markets research and computed indicators are not investment advice.